Universal Health (UHS) Tops Q2 EPS by 42c, Offers Guidance

Universal Health (NYSE: UHS) reported Q2 EPS of $5.35, $0.42 better than the analyst estimate of $4.93. Revenue for the quarter came in at $4.28 billion versus the consensus estimate of $4.24 billion.

GUIDANCE:

Universal Health sees FY2025 EPS of $20.00-$21.00, versus the consensus of $19.58. Universal Health sees FY2025 revenue of $17.1-17.31 billion, versus the consensus of $17.13 billion.

For earnings history and earnings-related data on Universal Health (UHS) click here.

You May Also Be Interested In

• Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
• Lantronix (LTRX) Reports In-Line Q4 EPS; Offers Guidance
• Ooma (OOMA) Tops Q2 EPS by 2c; offers guidance